Skip to Main Content
Skip Nav Destination

This chapter covers the advances made in epigenomics of type 2 diabetes, and how such work has elucidated the epigenetic underpinnings of this disease and its multiple complications. It discusses the developmental basis of diabetes, the causal role of gene–environment interactions in diabetes risk and pathogenesis, epigenetic dysregulation in multiple metabolic tissues, and the nanobiology of cell–cell communication in perpetuating such disease-relevant epigenetic changes. Finally, it delves into the translational potential of such studies on the development of biomarkers and therapeutic approaches for type 2 diabetes.

You do not currently have access to this chapter, but see below options to check access via your institution or sign in to purchase.
Don't already have an account? Register
Close Modal

or Create an Account

Close Modal
Close Modal